Caffeine in Hepatocellular Carcinoma: Cellular Assays, Animal Experiments, and Epidemiological Investigation
Liang Shan,1- 4,* Ning Zhao,2- 4,* Fengling Wang,1 Dandan Zhai,1 Jianjun Liu,1 Xiongwen Lv2- 4 1Department of Pharmacy, the Second People's Hospital of Hefei, Hefei Hospital Affiliated to Anhui Medical University, Hefei, Anhui, 230011, People's Republic of China; 2Anhui Pro...
Saved in:
Main Authors: | Shan L (Author), Zhao N (Author), Wang F (Author), Zhai D (Author), Liu J (Author), Lv X (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Caffeine in liver diseases: Pharmacology and toxicology
by: Liang Shan, et al.
Published: (2022) -
Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
by: Do Young Kim
Published: (2024) -
Real-Life Experience of Regorafenib in Patients With Advanced Hepatocellular Carcinoma
by: Jing-Yu Hou, et al.
Published: (2022) -
Systematic Investigation of Berberine for Treating Hepatocellular Carcinoma Based on Network Pharmacology
by: Mu Jie, et al.
Published: (2019) -
The Toxicity of Caffein: An experimental study on different species of animals
by: Rieger, J. B. (John Benjamin), 1886-; Salant, William